GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Sign Up For Our Newsletter

News Articles: psychedelics

Root extracts from the African shrub iboga have long been used in traditional healing rituals and more recently as an experimental treatment for depression and to reduce drug cravings in addiction. Scientists now are working on a version of the extract that doesn't cause heart attacks or hallucinations as side effects.

Progress Toward A Safer Psychedelic Drug To Treat Depression And Addiction

A synthetic version of the psychedelic drug ibogaine appears to relieve depression and addiction without producing hallucinations or other dangerous side effects — at least in rodents.

|
By:
  • Jon Hamilton
A renewed interest in the therapeutic value of psychedelics like MDMA and psilocybin to alleviate treatment-resistant psychiatric conditions has swept through clinical research circles.

When It Comes To Complex PTSD, Depression, Research Turns to Psychedelics For Treatment

People struggling with treatment-resistant PTSD may soon have a new course of care: MDMA. When used alongside psychotherapy, the synthetic substance in...

|
By: